Author

Taha Filali

Observed names: T Filali, T. Filali, T.P. Filali, Taha FILALI

Institution: University Frères Mentouri Constantine 1

Observed institutions: University Frères Mentouri Constantine 1, King Saud bin Abdulaziz University for Health Sciences, King Saud University, King Abdulaziz Medical City, The Netherlands Cancer Institute, Centre Hospitalo-Universitaire Dr Benbadis Constantine, King Abdullah International Medical Research Center, King Khalid University Hospital, University of Constantine 3, National Guard Health Affairs, Universidad de Murcia

OpenAlex ID: A5001536864

Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial

2023 · K. Alsaleh, H. Al Zahwahry, et al. · Journal of Cancer Research and Clinical Oncology · 18

PDF

First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome

2016 · H. Ziada-Bouchaar, K. Sifi, et al. · Familial Cancer · 12

Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria

2020 · F Smaili, A Boudjella, et al. · Cancer Treatment and Research Communications · 11

PDF

The Study of Druggable Targets in Nonsquamous Non-Small-Cell Lung Cancer in the Middle East and North Africa

2019 · Abdul Rahman Jazieh, Adda Bounedjar, et al. · Journal of Immunotherapy and Precision Oncology · 11

Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER+ breast cancer

2022 · Amira Boucenna, Khadidja Boudaoud, et al. · Egyptian Journal of Medical Human Genetics · 10

PDF

Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial

2021 · Khalid AlSaleh, Heba Al Zahwahry, et al. · JCO Global Oncology · 9

PDF

Association of TERT, OGG1, and CHRNA5 Polymorphisms and the Predisposition to Lung Cancer in Eastern Algeria

2020 · Asma Mimouni, Etienne Rouleau, et al. · Pulmonary Medicine · 7

PDF

Incidence of lung cancer in males and females in Algeria: The lung cancer registry in Algeria (LuCaReAl)

2020 · Adda Bounedjar, Radjâa Benkali, et al. · Cancer Epidemiology · 4

Epidemiology of Extranodal Diffuse Large B Cell Lymphomas in Algeria: A Study of the Algerian Group of Extranodal Lymphomas (GALEG)

2016 · S Hamdi, I Bentahar, et al. · Blood · 2

Clinicopathological characteristics and prognosis of non-small cell lung cancer in Algeria: a single-center retrospective study

2024 · Mohamed Lahmadi, Leila Beddar, et al. · BMC Cancer · 1

A multicentre, international neoadjuvant (NA), randomized, double-blind phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib in patients with operable luminal breast cancer (SAFIA Trial)

2019 · J-MA Nabholtz, K.A. Alsaleh, et al. · Annals of Oncology · 1

EP17.19: Realworld Evidence From a National Lung Cancer Study in Algeria: Late Stage Presentation and Gaps in Molecular Testing

2026 · a. Bounedjar, A. Bousahba, et al. · Journal of Thoracic Oncology

Epidemiological, clinical, and therapeutic characteristics of gallbladder cancer: a descriptive retrospective study.

2026 · Ines BOUKERZAZA, Dalal ZERROUK, et al. · Batna Journal of Medical Sciences (BJMS)

PDF

Abstract PS2-02-18: Real-world epidemiologic and biological characterisation of breast cancer in Algeria: A multicenter real world data study on 6044 patients

2026 · A. Bounedjar, M. A. Melzi, et al. · Clinical Cancer Research

P223: Analysis of Pathological Complete Response (pCR) Rates Based on HER2 LowScore and HER-0 in Luminal Breast Cancer Patients after Neoadjuvant Chemotherapy, A retrospective study

2025 · A. Boudersa, N. Kouadri, et al. · The Breast

150P Pathological complete response after neoadjuvant chemotherapy in HER2-positive breast cancer, efficacy of biosimilar compared to reference trastuzumab

2023 · N. Kouadri, N.N. Belili, et al. · ESMO Open

PDF

LES SARCOMES DES TISSUS MOUS : étude démographique, diagnostique et thérapeutique

2019 · N Djehal, T. Filali · journal algérien de médecine

Carcinome hépatocellulaire : profil épidémiologique, aspects cliniques, diagnostiques et modalités thérapeu-tiques. Expérience du centre de radiothérapie de Batna

2018 · Kamel Hamizi, T. Filali, et al. · Batna Journal of Medical Sciences (BJMS)

EP-1364: Methylenetetrahydrofolate Reductase C677T polymorphism in lung, rectal and breast cancer

2018 · K. Boudaoud, S. Taleb, et al. · Radiotherapy and Oncology

PDF

Oral Communication Abstracts of the 18th Pan Arab Cancer Congress. TUNISIA. April 19-21, 2018.

2018 · Mehdi Benna, Maher Slimane, et al. · PubMed

Poster abstracts of the 18th Pan Arab Cancer Congress. TUNISIA. April 19-21, 2018.

2018 · J Aarab, Ibtissem Abbess, et al. · PubMed

EP-1317: Prognostic and predictive factors in endometrial cancer

2016 · K. Boudaoud, S. Taleb, et al. · Radiotherapy and Oncology

Corrélation entre le polymorphisme C677 T du gène de la MTHFR et la toxicité des fluoropyrimidines chez les patients atteints d’un cancer rectal

2015 · K. Boudaoud, S. Taleb, et al. · Cancer/Radiothérapie

EP-1198: Methylenetetrahfolate reductase C677T polymorphism in patients treated for locally advanced rectal cancer

2015 · K. Boudaoud, S. Taleb, et al. · Radiotherapy and Oncology

PDF

P0171 Endemic undifferentiated nasopharyngeal carcinoma in algerian children and teenagers

2014 · K. Mazouzi, T.P. Filali, et al. · European Journal of Cancer

Works count: 33

Citation count: 86

H-index: 7

I10-index: 5